Founded in 1987, Genemed Biotechnologies introduces the patent-pending gene enrichment technology for amplifying large and rare target transcripts from cDNA. The company provides contract manufacturing services for a variety of research and diagnostic products, including native and recombinant proteins and nucleotides. It manufactures custom diagnostic reagents for various pharmaceutical and diagnostic companies. Genemed Biotechnologies staff includes scientists with doctorate degrees in several fields, including molecular biology, bio-organic chemistry, immunology, biochemistry, chemical engineering and microbiology. The company offers a variety of products for gene expression and RNA isolation. Its product line also includes GETLarge and GETRare, which are double stranded cDNA pools prepared from specific tissues. Genemed Biotechnologies is headquartered in South San Francisco, Calif.